Prognostic significance of p16/CDKN2A deletion in pleural mesotheliomas

被引：0
|
作者：
Dacic, S.
Poppei, H. H.
Kothmaier, H.
Halbwedt, I.
Morbini, P.
Murer, B.
Comin, C. E.
Galateau-Salle, F.
Demirag, F.
Zeren, H.
Allanoos, R.
Gibbs, A.
Cagle, P. T.
机构：
[1] Univ Pittsburgh, Pittsburgh, PA 15260 USA
[2] Inst Pathol, Graz, Austria
[3] Inst Pathol Anat, Pavia, Italy
[4] Osped Umberto 1, Venice, Italy
[5] Univ Florence, I-50121 Florence, Italy
[6] CHU Cote Nacre, Caen, France
[7] Ataturk Chest Dis Hosp, Ankara, Turkey
[8] Adana Univ, Adana, Turkey
[9] Llandough Hosp, Cardiff & Vale NHS Trust, Cardiff, Wales
[10] Methodist Hosp, Houston, TX USA
来源：
MODERN PATHOLOGY | 2008年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1547
引用
收藏
页码：339A / 340A
页数：2
相关论文
共 50 条
  • [31] Evaluation of p16 Protein Expression and CDKN2A Deletion in Conventional and Fibrosarcomatous Dermatofibrosarcoma Protuberans
    Siref, Andrew
    Patel, Vatsal
    Reith, John D.
    Balzer, Bonnie
    Shon, Wonwoo
    LABORATORY INVESTIGATION, 2017, 97 : 136A - 136A
  • [32] Evaluation of p16 Protein Expression and CDKN2A Deletion in Conventional and Fibrosarcomatous Dermatofibrosarcoma Protuberans
    Siref, Andrew
    Patel, Vatsal
    Reith, John D.
    Balzer, Bonnie
    Shon, Wonwoo
    MODERN PATHOLOGY, 2017, 30 : 136A - 136A
  • [33] Evaluation of p16 protein expression and CDKN2A deletion in conventional and fibrosarcomatous dermatofibrosarcoma protuberans
    Siref, Andrew
    Patel, Vatsal
    Reith, John D.
    Balzer, Bonnie L.
    Shon, Wonwoo
    PATHOLOGY, 2018, 50 (04) : 474 - 475
  • [34] Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas
    Vivian Tang
    Rufei Lu
    Kanish Mirchia
    Jessica Van Ziffle
    Patrick Devine
    Julieann Lee
    Joanna J. Phillips
    Arie Perry
    David R. Raleigh
    Calixto-Hope G. Lucas
    David A. Solomon
    Acta Neuropathologica, 2023, 145 : 497 - 500
  • [35] Comparison of cytoplasmic and nuclear expression loss of MTAP immunohistochemistry in pleural effusion cytologies and correlation with homozygous deletion of p16/CDKN2A
    Seker, N. S.
    Mulkem, O. F.
    Tekin, E.
    Ak, G.
    Metintas, M.
    Metintas, S.
    Dundar, E.
    VIRCHOWS ARCHIV, 2024, 485 : S147 - S147
  • [36] CDKN2A/p16 is inactivated by the combination of inversion and translocation
    Norris, Alexis L.
    Kamiyama, Hirohiko
    Hruban, Ralph H.
    Eshleman, James R.
    CANCER RESEARCH, 2015, 75
  • [37] Inactivation of CDKN2A gene (p16) in gallbladder carcinoma
    Roa, JC
    Vo, Q
    Araya, JC
    Villaseca, M
    Guzmán, P
    Ibacache, G
    de Aretxabala, X
    Roa, I
    REVISTA MEDICA DE CHILE, 2004, 132 (11) : 1369 - 1376
  • [38] Parental preferences for CDKN2A/p16 testing of minors
    Taber, Jennifer M.
    Aspinwall, Lisa G.
    Kohlmann, Wendy
    Dow, Reed
    Leachman, Sancy A.
    GENETICS IN MEDICINE, 2010, 12 (12) : 823 - 838
  • [39] CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure
    Kettunen, Eeva
    Savukoski, Sauli
    Salmenkivi, Kaisa
    Bohling, Tom
    Vanhala, Esa
    Kuosma, Eeva
    Anttila, Sisko
    Wolff, Henrik
    BMC CANCER, 2019, 19 (1)
  • [40] CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure
    Eeva Kettunen
    Sauli Savukoski
    Kaisa Salmenkivi
    Tom Böhling
    Esa Vanhala
    Eeva Kuosma
    Sisko Anttila
    Henrik Wolff
    BMC Cancer, 19
12345